ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $20,000 | -95.5% | 27,633 | -3.3% | 0.03% | +3.4% |
| Q4 2018 | $445,000 | +27.5% | 28,563 | +60.8% | 0.03% | +81.2% |
| Q3 2018 | $349,000 | -65.9% | 17,763 | -62.8% | 0.02% | -64.4% |
| Q4 2017 | $1,024,000 | +21.6% | 47,748 | +6.6% | 0.04% | -10.0% |
| Q4 2016 | $842,000 | -57.1% | 44,800 | -41.8% | 0.05% | -49.0% |
| Q2 2016 | $1,963,000 | +28.5% | 76,976 | +115.4% | 0.10% | +36.1% |
| Q4 2015 | $1,528,000 | -27.0% | 35,729 | -54.7% | 0.07% | -6.5% |
| Q3 2015 | $2,092,000 | -66.4% | 78,941 | -57.7% | 0.08% | -63.0% |
| Q2 2015 | $6,221,000 | +69.6% | 186,667 | +69.4% | 0.21% | +65.1% |
| Q1 2015 | $3,668,000 | +101.0% | 110,223 | +104.6% | 0.13% | +50.0% |
| Q3 2014 | $1,825,000 | +170.4% | 53,873 | +168.8% | 0.08% | +140.0% |
| Q2 2014 | $675,000 | -60.3% | 20,040 | -65.6% | 0.04% | -61.1% |
| Q4 2013 | $1,702,000 | +30.4% | 58,292 | +52.7% | 0.09% | +26.8% |
| Q3 2013 | $1,305,000 | -13.2% | 38,162 | -16.3% | 0.07% | +44.9% |
| Q2 2013 | $1,504,000 | – | 45,599 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |